ENDURITY MRI™ PACEMAKER

PREMIUM FEATURES

PHYSICIAN-PREFERRED SIZE AND SHAPE

The Endurity MRI™ pacemaker’s physician-preferred size¹ and physiologic shape help you minimize pocket size.¹

AUTOCAPTURE™ PACING SYSTEM

• Offers the maximum in threshold adaptability and patient safety with ventricular Beat-by-Beat™ capture confirmation
• Automatically delivers a 5.0 V backup safety pulse when noncapture is detected, and it may be programmed to either a bipolar or unipolar configuration

PROGRAMMABLE REAL-TIME ELECTROGRAM (EGM) WAVEFORM

Real-time electrogram (EGM) waveform, as well as the associated event markers that precede and follow a specific triggering event, can be programmed to automatically record up to 14 minutes of stored EGMs when encountering one or more programmable trigger options.

SPECIFIC FEATURES FOR OUR DUAL- AND SINGLE-CHAMBER MODELS

DUAL-CHAMBER

STATE-OF-THE-ART FEATURES

• Complete automaticity (atrial and ventricular)
• Ventricular Intrinsic Preference (VIP™) technology
• AF Suppression™ algorithm and SenseAbility™ technology—designed to deliver optimal therapy for patients at implant and throughout their lives

PROGRAMMABLE AT/AF ALERTS

The only pacemaker with programmable AT/AF alerts specifically indicated for detecting atrial tachyarrhythmias, which have been found to be associated with an increased risk of stroke in elderly, hypertensive, pacemaker patients without prior history of AF.²

LONGEVITY

• Outstanding longevity provides 9.4 years of service life,³ which is supported by an 8-year warranty⁴
• 6-month ERI-EOL interval

SINGLE-CHAMBER

STATE-OF-THE-ART FEATURES

• Automaticity
• Ventricular AutoCapture™ pacing system
• SenseAbility™ technology designed to deliver optimal therapy for patients

LONGEVITY

• Outstanding longevity provides 14.4 years of service life,³ which is supported by a 10-year warranty⁴
• 6-month ERI-EOL interval

BUILDING COMPREHENSIVE CARDIAC ARRHYTHMIA MANAGEMENT

The Endurity MRI™ pacemaker is part of our arrhythmia management portfolio. Our vision is to transform the treatment of cardiac arrhythmias by designing cost-effective technologies that improve outcomes. Read more about our approach to cardiac arrhythmia management.

RESOURCES AND DOCUMENTATION

Product Manuals (Instructions for Use)

REFERENCES

1. St. Jude Medical. Data on file, Report 60048640. Market Research Report: Pacemaker Size and Shape, 2012.
2. Healey, J. S., Connolly, S. J., Gold, M.R., Israel, C. W., Van Gelder, I. C., Capucci, A., … Hohnloser, S. H. (2012). Subclinical atrial fibrillation and the risk of stroke. NEW ENGLAND JOURNAL OF MEDICINE, 366, 120-129. http://dx.doi.org/10.1056/NEJMoa1105575
3. A,V = 2,5 V @ 0,4 ms; 500 ohms; 100% VVI pacing @ 60 bpm; AutoCapture™ Pacing System OFF; SEGMs ON.
4. Terms and conditions apply; refer to the warranty for details.

ENDURITY MRI™

Single-Chamber Pacemaker

Contents: MRI Ready Pacing System

SPECIFICATIONS

ENDURITY MRI™

Dual-Chamber Pacemaker

Contents: MRI Ready Pacing System

SPECIFICATIONS

CLINICAL ADVANTAGES

MRI READY

Abbott recognized the importance of MR Conditional devices, so we designed accordingly.

Patients over 65 are at greater risk for stroke, dementia and musculoskeletal disorders.¹

• Physicians prefer MR Conditional pacemakers when diagnosing many conditions, including those affecting the brain and spine²
• The Endurity MRI™ pacemaker allows for whole-body MRI scans depending on the MRI Ready lead(s) selected*
• The Endurity MRI pacemaker enables 1.5T or 3.0T MRI scans when used with Abbott MRI Ready leads*
• The St. Jude Medical MRI Activator™ handheld device is an optional, easy-to-use device that can be used to program the pacemaker to pre-approval MRI settings pre- and post-MRI scan, decreasing the number of workflow steps and increasing clinical efficiency

MINIMIZE RISK OF HEART FAILURE HOSPITALIZATION

Unnecessary right ventricular (RV) pacing can exacerbate heart conditions.

• Pacing > 40% can lead to increased HF hospitalizations and mortality³
• Patients with low RV pacing (0-9%) have same negative outcomes as those with high RV pacing (40-49%)⁴

Abbott can help. We use a Ventricular Intrinsic Preference (VIP™) algorithm with dynamic AV delay, which are clinically proven to reduce unnecessary RV pacing. The VIP algorithm is shown to reduce heart-failure related hospitalization,⁵ and we offer RV pacing at desirable levels (10-19%).⁴

BUILDING COMPREHENSIVE CARDIAC ARRHYTHMIA MANAGEMENT

The Endurity MRI™ pacemaker is part of our arrhythmia management portfolio. Our vision is to transform the treatment of cardiac arrhythmias by designing cost-effective technologies that improve outcomes. Read more about our approach to cardiac arrhythmia management.

REFERENCES

* See MRI Scan Parameters – Lead Models in MRI Scan Parameters
1. Levy, S. THE MOST COMMON ISSUES OF AGING. www.agingcare.com/Articles/common-issues-of-aging-102224.html
2. Jauch, E. C., Saver, J. L., Adams, H. P. Jr., Bruno, A., Connors, J. J., Demaerschalk, B. M., … Yonas, H. (2013). Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 44(3), 870-947. http://dx.doi.org/10.1161/STR.0b013e318284056a
3. Wilkoff, B. L., Cook, J. R., Epstein, A. E., Greene, H. L., Hallstrom, A. P., Hsia, H., … Sharma, A., & DAVID Investigators. (2002). Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA, 288(24), 3115-3123. http://www.ncbi.nlm.nih.gov/pubmed/12495391
4. Olshansky, B., Day, J., Lerew, D., Brown, S., Stolen, K. Q., & INTRINSIC RV Investigators. Eliminating right ventricular pacing may not be best for patients requiring implantable cardioverter-defibrillators. Heart Rhythm, (7), 886-891. http://www.ncbi.nlm.nih.gov/pubmed/17599672
5. Faulknier, B., & Richards, M. (2012, December). The association of the use of the Ventricular Intrinsic Preference (VIP™) feature with heart failure hospitalization in pacemaker patients. Presented at the International Symposium on Progress in Clinical Pacing, Rome, Italy.